Education and Training
- Fellowship in Cardiology, Medicine, Duke University School of Medicine, 1997 - 2001
- Residency in Internal Medicine, Medicine, Brigham and Women's Hospital, 1994 - 1997
- M.D., Harvard Medical School, 1994
Hart, SA, Devendra, G, Kim, Y, Kalahasti, V, Flamm, S, and Krasuski, R. "CAN SELECTIVE PULMONARY VASODILATOR THERAPY BE USED TO TARGET PULMONIC REGURGITATION? RESULTS OF THE PINOT NOIR TRIAL.": Elsevier BV, March 2012.
Hart, SA, Devendra, G, Kim, Y, Kalahasti, V, Flamm, S, and Krasuski, R. "SELECTIVE PULMONARY VASODILATATION IMPROVES LEFT VENTRICULAR-RIGHT VENTRICULAR COUPLING IN PATIENTS WITH SIGNIFICANT PULMONARY VALVE REGURGITATION.": Elsevier BV, March 2012.
Hart, S, Devendra, G, Kim, YY, Flamm, SD, Kalahasti, S, Arruda, J, Walker, E, Boonyasiranant, T, Bolen, M, Setser, RM, and Krasuski, R. "PINOT NOIR: Pulmonic INsufficiency imprOvemenT with Nitric Oxide Inhalational Response." Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance 14, no. Suppl 1 (January 2012): O73-O73.
Elmallah, W, and Krasuski, RA. "Therapy and clinical trials." Current opinion in lipidology 22, no. 6 (December 2011): 512-513.
Krasuski, RA, Kalahasti, V, Hobbs, R, Hart, S, Magyar, D, Lorber, R, Pettersson, G, and Blackstone, E. "Response to letter regarding article, "long-term outcome and impact of surgery on adults with coronary arteries originating from the opposite coronary cusp"." Circulation 124, no. 14 (October 4, 2011). (Letter)
Krasuski, RA, Cater, GM, Devendra, GP, Wolski, K, Shishehbor, MH, Nissen, SE, Oberti, C, and Ellis, SG. "Downstream coronary effects of drug-eluting stents." American heart journal 162, no. 4 (October 2011): 764-771.e1.
Devendra, GP, Hart, SA, Kim, YY, Setser, RM, Flamm, SD, and Krasuski, RA. "Modified INOvent for delivery of inhaled nitric oxide during cardiac MRI." Magnetic resonance imaging 29, no. 8 (October 2011): 1145-1149.
Krasuski, RA, Hart, SA, Smith, B, Wang, A, Harrison, JK, and Bashore, TM. "Association of anemia and long-term survival in patients with pulmonary hypertension." Int J Cardiol 150, no. 3 (August 4, 2011): 291-295.
Krasuski, RA, Devendra, GP, Hart, SA, Rane, A, Lee, J, and Bashore, TM. "Unmasked pulmonary venous hypertension during vasodilator challenge predicts poor outcomes with medical therapy." August 2011.
Krasuski, RA, Devendra, GP, Cater, G, and Whitney, EJ. "The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study." The American journal of the medical sciences 341, no. 5 (May 2011): 378-382.